BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17335913)

  • 1. Biophysical characterization of vaccinia virus thymidine kinase substrate utilization.
    Smith RF; Freyer MW; Lewis EA
    J Virol Methods; 2007 Jun; 142(1-2):151-8. PubMed ID: 17335913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of vaccinia virus thymidine kinase in complex with dTTP: insights for drug design.
    El Omari K; Solaroli N; Karlsson A; Balzarini J; Stammers DK
    BMC Struct Biol; 2006 Oct; 6():22. PubMed ID: 17062140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substrate specificity of three viral thymidine kinases (TK): vaccinia virus TK, feline herpesvirus TK, and canine herpesvirus TK.
    Solaroli N; Johansson M; Balzarini J; Karlsson A
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1189-92. PubMed ID: 17065088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.
    Hussein IT; Miguel RN; Tiley LS; Field HJ
    Arch Virol; 2008; 153(3):495-505. PubMed ID: 18196203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-level expression and purification of human thymidine kinase 1: quaternary structure, stability, and kinetics.
    Birringer MS; Perozzo R; Kut E; Stillhart C; Surber W; Scapozza L; Folkers G
    Protein Expr Purif; 2006 Jun; 47(2):506-15. PubMed ID: 16473525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate specificity of feline and canine herpesvirus thymidine kinase.
    Solaroli N; Johansson M; Persoons L; Balzarini J; Karlsson A
    Antiviral Res; 2008 Aug; 79(2):128-32. PubMed ID: 18455811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-substrate interactions with an antibiotic resistance enzyme: aminoglycoside nucleotidyltransferase(2'')-Ia characterized by kinetic and thermodynamic methods.
    Wright E; Serpersu EH
    Biochemistry; 2005 Aug; 44(34):11581-91. PubMed ID: 16114895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase.
    Black ME; Hruby DE
    J Biol Chem; 1992 May; 267(14):9743-8. PubMed ID: 1577811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the binding of 5-substituted 2'-deoxyuridine substrates to thymidine kinase of herpes simplex virus type-1.
    De Winter H; Herdewijn P
    J Med Chem; 1996 Nov; 39(24):4727-37. PubMed ID: 8941385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling.
    Christians FC; Scapozza L; Crameri A; Folkers G; Stemmer WP
    Nat Biotechnol; 1999 Mar; 17(3):259-64. PubMed ID: 10096293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed spectroscopic, thermodynamic, and kinetic studies on the protolytic equilibria of Fe(III)cydta and the activation of hydrogen peroxide.
    Brausam A; Maigut J; Meier R; Szilágyi PA; Buschmann HJ; Massa W; Homonnay Z; van Eldik R
    Inorg Chem; 2009 Aug; 48(16):7864-84. PubMed ID: 19618946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
    Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
    Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mitochondrial thymidine kinase is selectively inhibited by 3'-thiourea derivatives of beta-thymidine: identification of residues crucial for both inhibition and catalytic activity.
    Balzarini J; Van Daele I; Negri A; Solaroli N; Karlsson A; Liekens S; Gago F; Van Calenbergh S
    Mol Pharmacol; 2009 May; 75(5):1127-36. PubMed ID: 19233899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding.
    Black ME; Hruby DE
    J Biol Chem; 1992 Apr; 267(10):6801-6. PubMed ID: 1551887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a capillary electrophoresis method for the characterization of herpes simplex virus type 1 (HSV-1) thymidine kinase substrates and inhibitors.
    Iqbal J; Scapozza L; Folkers G; Müller CE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 846(1-2):281-90. PubMed ID: 17023224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.
    Hernandez AI; Familiar O; Negri A; Rodríguez-Barrios F; Gago F; Karlsson A; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    J Med Chem; 2006 Dec; 49(26):7766-73. PubMed ID: 17181158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine- and ADP-phosphorylating capacity of herpes simplex virus-induced thymidine kinase enzyme complex.
    Labenz J; Friedrich D; Müller WE; Falke D
    Intervirology; 1983; 19(2):77-84. PubMed ID: 6305867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate specificity of vaccinia virus thymidylate kinase.
    Topalis D; Collinet B; Gasse C; Dugué L; Balzarini J; Pochet S; Deville-Bonne D
    FEBS J; 2005 Dec; 272(24):6254-65. PubMed ID: 16336263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the ATP-binding domain of vaccinia virus thymidine kinase.
    Black ME; Hruby DE
    J Biol Chem; 1990 Oct; 265(29):17584-92. PubMed ID: 2211649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.